West Lafayette, Indiana
Ernst & Young US LLP
Prior to a rebranding to Inotiv in 2019 and a formal name change in 2021, the company was Bioanalytical Systems, Inc., and the initial public stock offering was completed in November 1997.
September 30
Our common shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “NOTV”.
We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on, among other factors, our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant. Any return to shareholders will therefore be limited to the appreciation in the value of their stock, if any.
The transfer agent and registrar for our common shares is Computershare Limited.
To contact our transfer agent:
First Class, Registered or Certified mail: Computershare Investor Services PO Box 43006 Providence, RI 02940-3006
Overnight Delivery or Courier Services: Computershare Investor Services 150 Royall Street, Suite 101 Canton, MA 02021
Shareholder Services Toll Free: 1-877-581-5548 Shareholder Services Outside of the US and Canada: 781-575-2879 Investor CentreTM portal: www.computershare.com/investor
Latest corporate news here.
Investor Relations Devin Sullivan (212) 836-9608 dsullivan@equityny.com
SEC Filings here.
Get added to Inotiv’s email distribution list here.